FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Equine Vet J / BEVA primary care clinical guidelines: Equine parasite contr...
Equine veterinary journal2024; 56(3); 392-423; doi: 10.1111/evj.14036

BEVA primary care clinical guidelines: Equine parasite control.

Abstract: There is a lack of consensus on how best to balance our need to minimise the risk of parasite-associated disease in the individual horse, with the need to limit the use of anthelmintics in the population to preserve their efficacy through delaying further development of resistance. Objective: To develop evidence-based guidelines utilising a modified GRADE framework. Methods: A panel of veterinary scientists with relevant expertise and experience was convened. Relevant research questions were identified and developed with associated search terms being defined. Evidence in the veterinary literature was evaluated using the GRADE evidence-to-decision framework. Literature searches were performed utilising CAB abstracts and PubMed. Where there was insufficient evidence to answer the research question the panel developed practical guidance based on their collective knowledge and experience. Results: Search results are presented, and recommendation or practical guidance were made in response to 37 clinically relevant questions relating to the use of anthelmintics in horses. Conclusions: There was insufficient evidence to answer many of the questions with any degree of certainty and practical guidance frequently had to be based upon extrapolation of relevant information and the panel members' collective experience and opinions. Conclusions: Equine parasite control practices and current recommendations have a weak evidence base. These guidelines highlight changes in equine parasite control that should be considered to reduce the threat of parasite-associated disease and delay the development of further anthelmintic resistance.
© 2024 EVJ Ltd.
Get Full Text
Publication Date: 2024-01-02 PubMed ID: 38169127DOI: 10.1111/evj.14036Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article
  • Review

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research article is about the creation of evidence-based guidelines for equine parasite control. Lack of agreement and understanding in the field motivated the study, which aims to balance minimizing risk of disease in horses with limiting some treatments to prevent resistance from developing.

Research Methodology

  • The researchers gathered a panel of scientists specializing in veterinary medicine to create a guide for parasite control in horses based on available evidence and practical knowledge of the professionals.
  • The panel defined and developed relevant research questions, as well as their associated search terms.
  • They used the GRADE evidence-to-decision framework to evaluate the evidence found, filtering their options via both CAB abstracts and PubMed.
  • Where there was insufficient evidence to conclusively answer the research question, the panel members supplemented with practical guidance drawn from their own knowledge and experience.

Research Findings

  • The team distilled their data into a set of observations and recommendations responding to 37 clinically relevant questions related to the utilization of anthelmintics (anti-parasitic drugs) in horses.
  • Many of the questions had insufficient evidence for a definitive answer, so practical guidance often relied on extrapolation of relevant information and the panel’s collective experience and opinion.

Research Conclusions

  • The research concluded that current practices and recommendations for equine parasite control are based on a weak evidence base.
  • The guidelines produced by this research emphasize changes to equine parasite control practices that should be considered, including reducing the risk of parasite-associated disease and delaying the development of anthelmintic resistance.

Cite This Article

APA
Rendle D, Hughes K, Bowen M, Bull K, Cameron I, Furtado T, Peachey L, Sharpe L, Hodgkinson J. (2024). BEVA primary care clinical guidelines: Equine parasite control. Equine Vet J, 56(3), 392-423. https://doi.org/10.1111/evj.14036

Publication

Equine veterinary journal
ISSN: 2042-3306
NlmUniqueID: 0173320
Country: United States
Language: English
Volume: 56
Issue: 3
Pages: 392-423

Researcher Affiliations

Rendle, David
  • EMT Consulting, Tiverton, UK.
Hughes, Kristopher
  • School of Agricultural, Environmental and Veterinary Sciences, Charles Sturt University, Wagga Wagga, New South Wales, Australia.
Bowen, Mark
  • Medicine Vet Referrals, Nottinghamshire, UK.
Bull, Katie
  • Bristol Veterinary School, University of Bristol, Bristol, UK.
Cameron, Ian
  • Rossdales Equine Hospital, Newmarket, UK.
Furtado, Tamzin
  • Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Neston, UK.
Peachey, Laura
  • Bristol Veterinary School, University of Bristol, Bristol, UK.
Sharpe, Laura
  • George Vet Group, Malmesbury, UK.
Hodgkinson, Jane
  • Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Neston, UK.

MeSH Terms

  • Animals
  • Horses
  • Horse Diseases / epidemiology
  • Anthelmintics / therapeutic use
  • Communicable Disease Control
  • Primary Health Care
  • Parasite Egg Count / veterinary
  • Drug Resistance
  • Feces

References

This article includes 361 references
  1. Bowen IM, Redpath A, Burford JH, Hallowell GD, Dugdale A, Watson T. BEVA primary care clinical guidelines: analgesia.. Equine Vet J 2019;52:13–27.
  2. Woolf S, Schünemann HJ, Eccles MP, Grimshaw JM, Shekelle P. Developing clinical practice guidelines: types of evidence and outcomes; values and economics, synthesis, grading, and presentation and deriving recommendations.. Implement Sci 2012;7:61.
  3. Kumar A, Miladinovic B, Guyatt GH, Schünemann HJ, Djulbegovic B. GRADE guidelines system is reproducible when instructions are clearly operationalized even among the guidelines panel members with limited experience with GRADE.. J Clin Epidemiol 2016;75:115–118.
  4. Freeman SL, Ashton NM, Elce YA, Hammond A, Hollis AR, Quinn G. BEVA primary care clinical guidelines: wound management in the horse.. Equine Vet J 2020;53(1):18–29.
  5. Nielsen MK. Anthelmintic resistance in equine nematodes: current status and emerging trends.. Int J Parasitol Drugs Drug Resist 2022;20:76–88.
  6. Love S, Duncan JL. Could the worms have turned?. Equine Vet J 1991;23(152):154.
  7. Rendle D, Austin C, Bowen M, Cameron I, Furtado T, Hodgkinson J. Equine de‐worming: a consensus on current best practice.. UK‐Vet Equine 2019;3(S1):1–14.
  8. Rendle D, Mountford D, Roberts C, Owers R, Mair T, Bowen M. Anthelmintic resistance in equids.. Vet Rec 2021;188:230–231.
  9. Suarez VH, Lifschitz AL, Sallovitz JM, Lanusse CE. Effects of ivermectin and doramectin faecal residues on the invertebrate colonization of cattle dung.. J Appl Èntomol 2003;127:481–488.
  10. Robertson R, Wentworth J. UK insect decline and extinctions.. London: UK Parliament Post 2020.
  11. Douglas J, Owers R, Campbell MLH. Social licence to operate: what can equestrian sports learn from other industries?. Animals (Basel) 2022;12:1987.
  12. . AAEP Internal Parasite Control Guidelines.. .
  13. . A guide to the treatment and control of equine gastrointestinal parasite infections, 2nd ed.. European Scientific Counsel Companion Animal Parasites 2019.
  14. Matthews J, Tzelos T, Lester H. Guidelines for the control of worms in horses.. The Horse Trust .
  15. . What is GRADE?. BMJ Best Practice .
  16. Nielsen MK, Branan MA, Wiedenheft AM, Digianantonio R, Scare JA, Bellaw JL. Risk factors associated with strongylid egg count prevalence and abundance in the United States equine population.. Vet Parasitol 2018;257:58–68.
  17. Hernández JÁ, Sánchez‐Andrade R, Cazapal‐Monteiro CF, Arroyo FL, Sanchís JM, Paz‐Silva A. A combined effort to avoid strongyle infection in horses in an oceanic climate region: rotational grazing and parasiticidal fungi.. Parasite Vector 2018;11:240.
  18. Herd RP. Epidemiology and control of equine strongylosis at Newmarket.. Equine Vet J 1986;18:447–452.
  19. Matthee S, Krecek RC, Milne SA, Boshoff M, Guthrie AJ. Impact of management interventions on helminth levels, and body and blood measurements in working donkeys in South Africa.. Vet Parasitol 2002;107:103–113.
  20. Corbett CJ, Love S, Moore A, Burden FA, Matthews JB, Denwood MJ. The effectiveness of faecal removal methods of pasture management to control the cyathostomin burden of donkeys.. Parasite Vector 2014;7:48.
  21. Aromaa M, Hautala K, Oksanen A, Sukura A, Näreaho A. Parasite infections and their risk factors in foals and young horses in Finland.. Vet Parasitol Reg Stud Rep 2018;12:35–38.
  22. Nielsen MK, Baptiste KE, Tolliver SC, Collins SS, Lyons ET. Analysis of multiyear studies in horses in Kentucky to ascertain whether counts of eggs and larvae per gram of feces are reliable indicators of numbers of strongyles and ascarids present.. Vet Parasitol 2010;174:77–84.
  23. Hautala K, Näreaho A, Kauppinen O, Nielsen MK, Sukura A, Rajala‐Schultz PJ. Risk factors for equine intestinal parasite infections and reduced efficacy of pyrantel embonate against Parascaris sp.. Vet Parasitol 2019;273:52–59.
  24. Fritzen B, Rohn K, Schnieder T, Samson‐Himmelstjerna GV. Endoparasite control management on horse farms—lessons from worm prevalence and questionnaire data.. Equine Vet J 2010;42:79–83.
  25. Arfuso F, Bazzano M, Brianti E, Gaglio G, Passantino A, Tesei B. Nutritional supplements containing Cardus mariano, Eucalyptus globulus, Gentiana lutea, Urtica urens, and Mallotus philippinensis extracts are effective in reducing egg shedding in dairy jennies (Equus asinus) naturally infected by cyathostomins.. Frontiers Vet Sci 2020;7:556270.
  26. Payne SE, Kotze AC, Durmic Z, Vercoe PE. Australian plants show anthelmintic activity toward equine cyathostomins in vitro.. Vet Parasitol 2013;196:153–160.
  27. Hoste H, Jackson F, Athanasiadou S, Thamsborg SM, Hoskin SO. The effects of tannin‐rich plants on parasitic nematodes in ruminants.. Trends Parasitol 2006;22:253–261.
  28. Paz‐Silva A, Francisco I, Valero‐Coss RO, Cortiñas FJ, Sánchez JA, Francisco R. Ability of the fungus Duddingtonia flagrans to adapt to the cyathostomin egg‐output by spreading chlamydospores.. Vet Parasitol 2011;179:277–282.
  29. Buono F, Pacifico L, Piantedosi D, Sgroi G, Neola B, Roncoroni C. Preliminary observations of the effect of garlic on egg shedding in horses naturally infected by intestinal strongyles.. J Equine Vet 2018;72:79–83.
  30. Pearson W, Boermans HJ, Bettger WJ, McBride BW, Lindinger MI. Association of maximum voluntary dietary intake of freeze‐dried garlic with Heinz body anemia in horses.. Am J Vet Res 2005;66:457–465.
  31. Peachey LE, Pinchbeck GL, Matthews JB, Burden FA, Mulugeta G, Scantlebury CE. An evidence‐based approach to the evaluation of ethnoveterinary medicines against strongyle nematodes of equids.. Vet Parasitol 2015;210:40–52.
  32. Arroyo FL, Arias MS, Cazapal‐Monteiro CF, Hernández JA, Suárez J, Miguélez S. The capability of the fungus Mucor circinelloides to maintain parasiticidal activity after the industrial feed pelleting enhances the possibilities of biological control of livestock parasites.. Biol Control 2016;92:38–44.
  33. Relf VE, Morgan ER, Hodgkinson JE, Matthews JB. Helminth egg excretion with regard to age, gender and management practices on UK thoroughbred studs.. Parasitology 2013;140(641):652.
  34. Wood ELD, Matthews JB, Stephenson S, Slote M, Nussey DH. Variation in fecal egg counts in horses managed for conservation purposes: individual egg shedding consistency, age effects and seasonal variation.. Parasitology 2013;140:115–128.
  35. Döpfer D, Kerssens CM, Meijer YGM, Boersema JH, Eysker M. Shedding consistency of strongyle‐type eggs in dutch boarding horses.. Vet Parasitol 2004;124:249–258.
  36. Sallé G, Cortet J, Koch C, Reigner F, Cabaret J. Economic assessment of FEC‐based targeted selective drenching in horses.. Vet Parasitol 2015;214:159–166.
  37. Roelfstra L, Quartier M, Pfister K. Preliminary data from six years of selective anthelmintic treatment on five horse farms in France and Switzerland.. Animals 2020;10:2395.
  38. Lester HE, Bartley DJ, Morgan ER, Hodgkinson JE, Stratford CH, Matthews JB. A cost comparison of faecal egg count‐directed anthelmintic delivery versus interval programme treatments in horses.. Vet Rec 2013;173:371.
  39. Sallé G, Cortet J, Bois I, Dubès C, Guyot‐Sionest Q, Larrieu C. Risk factor analysis of equine strongyle resistance to anthelmintics.. BioRxiv 2017;7:158105.
  40. Nielsen MK, Sauermann CW, Leathwick DM. The effect of climate, season, and treatment intensity on anthelmintic resistance in cyathostomins: a modelling exercise.. Vet Parasitol 2019;269:7–12.
  41. Leathwick DM, Sauermann CW, Nielsen MK. (2019) managing anthelmintic resistance in cyathostomin parasites: investigating the benefits of refugia‐based strategies.. Int J Parasitol Drugs Drug Resist 2019;10:118–124.
  42. Geurden T, Keersmaecker FD, Keersmaecker SD, Claerebout E, Leathwick DM, Nielsen MK. Three‐year study to evaluate an anthelmintic treatment regimen with reduced treatment frequency in horses on two study sites in Belgium.. Vet Parasitol 2021;298:109538.
  43. Sauermann CW, Nielsen MK, Luo D, Leathwick DM. Modelling the development of anthelmintic resistance in cyathostomin parasites: the importance of genetic and fitness parameters.. Vet Parasitol 2019;269:28–33.
  44. O'Sullivan B. Crofton weed (Eupatorium adenophorum) toxicity in horses.. Aust Vet J 1979;55:19–21.
  45. Joó K, Trúzsi RL, Kálmán CZ, Ács V, Jakab S, Bába A. Evaluation of risk factors affecting strongylid egg shedding on Hungarian horse farms.. Vet Parasitol Reg Stud Rep 2022;27:100663.
  46. Becher AM, Mahling M, Nielsen MK, Pfister K. Selective anthelmintic therapy of horses in the federal states of Bavaria (Germany) and Salzburg (Austria): an investigation into strongyle egg shedding consistency.. Vet Parasitol 2010;171:116–122.
  47. Denwood MJ, Love S, Innocent GT, Matthews L, Mckendrick IJ, Hillary N. Quantifying the sources of variability in equine faecal egg counts: implications for improving the utility of the method.. Vet Parasitol 2012;188:120–126.
  48. Kuhnert‐Paul Y, Schmäschke R, Daugschies A. Effect of distribution of eggs of strongyles and Parascaris equorum in faecal samples of horses on detection with a combined sedimentation‐flotation method.. Tierarztliche Praxis Ausgabe Grosstiere Nutztiere 2012;40:21–26.
  49. Lester HE, Matthews JB. Faecal worm egg count analysis for targeting anthelmintic treatment in horses: points to consider.. Equine Vet J 2014;46:139–145.
  50. Nielsen MK, Vidyashankar AN, Andersen UV, Delisi K, Pilegaard K, Kaplan RM. Effects of fecal collection and storage factors on strongylid egg counts in horses.. Vet Parasitol 2010;167:55–61.
  51. Schurer J, Davenport L, Wagner B, Jenkins E. Effects of sub‐zero storage temperatures on endoparasites in canine and equine feces.. Vet Parasitol 2014;204:310–315.
  52. Crawley JAH, Chapman SN, Lummaa V, Lynsdale CL. Testing storage methods of faecal samples for subsequent measurement of helminth egg numbers in the domestic horse.. Vet Parasitol 2016;221:130–133.
  53. Sengupta ME, Thapa S, Thamsborg SM, Mejer H. Effect of vacuum packing and temperature on survival and hatching of strongyle eggs in faecal samples.. Vet Parasitol 2016;217:21–24.
  54. Nielsen MK, Doran D, Slusarewicz P. Effects of sample homogenizing on the performance of an automated strongylid egg counting system.. Vet Parasitol 2021;300:109623.
  55. Cringoli G, Rinaldi L, Maurelli MP, Utzinger J. FLOTAC: new multivalent techniques for qualitative and quantitative copromicroscopic diagnosis of parasites in animals and humans.. Nat Protoc 2010;5:503–515.
  56. Cringoli G, Maurelli MP, Levecke B, Bosco A, Vercruysse J, Utzinger J. The mini‐FLOTAC technique for the diagnosis of helminth and protozoan infections in humans and animals.. Nat Protoc 2017;12:1723–1732.
  57. Godber OF, Phythian CJ, Bosco A, Ianniello D, Coles G, Rinaldi L. A comparison of the FECPAK and mini‐FLOTAC faecal egg counting techniques.. Vet Parasitol 2015;207:342–345.
  58. Cain JL, Peters KT, Suri P, Roher A, Rutledge MH, Nielsen MK. The effect of analyst training on fecal egg counting variability.. Parasitol Res 2021;120:1363–1370.
  59. Slusarewicz M, Slusarewicz P, Nielsen MK. The effect of counting duration on quantitative fecal egg count test performance.. Vet Parasitol X 2019;2:100020.
  60. Noel ML, Scare JA, Bellaw JL, Nielsen MK. Accuracy and precision of mini‐FLOTAC and McMaster techniques for determining equine strongyle egg counts.. J Equine Vet 2017;48:182–187.
  61. Scare JA, Slusarewicz P, Noel ML, Wielgus KM, Nielsen MK. Evaluation of accuracy and precision of a smartphone based automated parasite egg counting system in comparison to the McMaster and mini‐FLOTAC methods.. Vet Parasitol 2017;247:85–92.
  62. Bosco A, Maurelli MP, Ianniello D, Morgoglione ME, Amadesi A, Coles GC. The recovery of added nematode eggs from horse and sheep faeces by three methods.. BMC Vet Res 2018;14:7.
  63. Nápravníková J, Petrtýl M, Stupka R, Vadlejch J. Reliability of three common fecal egg counting techniques for detecting strongylid and ascarid infections in horses.. Vet Parasitol 2019;272:53–57.
  64. Kuzmina TA, Dzeverin I, Kharchenko VA. Strongylids in domestic horses: influence of horse age, breed and deworming programs on the strongyle parasite community.. Vet Parasitol 2016;227:56–63.
  65. Tyson F, Dalesman S, Brophy PM, Morphew RM. Novel equine faecal egg diagnostics: validation of the FECPAKG2.. Animals (Basel) 2020;10:1254.
  66. Norris JK, Slusarewicz P, Nielsen MK. Pixel by pixel: real‐time observation and quantification of passive flotation speeds of three common equine endoparasite egg types.. Int J Parasitol 2019;49:885–892.
  67. Boersema JH, Borgsteede FHM, Eysker M, Saedt I. The reappearance of strongyle eggs in faeces of horses treated with pyrantel embonate.. Vet Q 1995;17:18–20.
  68. Von Samson‐Himmelstjerna G, Traversa D, Demeler J, Rohn K, Milillo P, Schurmann S. Effects of worm control practices examined by a combined faecal egg count and questionnaire survey on horse farms in Germany, Italy and the UK.. Parasite Vector 2009;2(S3):7.
  69. Lind EO, Christensson D. Anthelmintic efficacy on Parascaris equorum in foals on Swedish studs.. Acta Vet Scand 2009;51:45.
  70. Elghryani N, McOwan T, Mincher C, Duggan V, de Waal T. Estimating the prevalence and factors affecting the shedding of helminth eggs in Irish equine populations.. Animals (Basel) 2023;13:581.
  71. Chapman MR, French DD, Klei TR. Prevalence of strongyle nematodes in naturally infected ponies of different ages and during different seasons of the year in Louisiana.. J Parasitol 2003;89:309–314.
  72. Boelow H, Krücken J, von Samson‐Himmelstjerna G. Epidemiological study on factors influencing the occurrence of helminth eggs in horses in Germany based on sent‐in diagnostic samples.. Parasitol Res 2023;122:749–767.
  73. Kaplan RM, Denwood MJ, Nielsen MK, Thamsborg SM, Torgerson PR, Gilleard JS. World Association for the Advancement of veterinary parasitology (W.A.A.V.P.) guideline for diagnosing anthelmintic resistance using the faecal egg count reduction test in ruminants, horses and swine.. Vet Parasitol 2023;318:109936.
  74. Pereira MC, Kohek I, Campos R, Lima SB, Foz RPP. A field evaluation of anthelmintics for control of cyathostomes of horses in Brazil.. Vet Parasitol 1991;38:121–129.
  75. Lyons ET, Tolliver SC, Drudge JH. Critical tests in equids with fenbendazole alone or combined with piperazine: particular reference to activity on benzimidazole‐resistant small strongyles.. Vet Parasitol 1983;12:91–98.
  76. Barger IA, James RE, Davies HI. Evaluation of paste formulations of fenbendazole plus piperazine against benzimidazole‐resistant cyathostomes in horses.. Aust Vet J 1985;62:139–140.
  77. Scare JA, Lyons ET, Wielgus KM, Nielsen MK. Combination deworming for the control of double‐resistant cyathostomin parasites – short and long term consequences.. Vet Parasitol 2018;251:112–118.
  78. Kaplan RM, West EM, Norat‐Collazo LM, Vargas J. A combination treatment strategy using pyrantel pamoate and oxibendazole demonstrates additive effects for controlling equine cyathostomins.. Equine Vet Educ 2014;26(485):491.
  79. Nielsen MK, Banahan M, Kaplan RM. Importation of macrocyclic lactone resistant cyathostomins on a US thoroughbred farm.. Int J Parasitol Drugs Drug Resist 2020;14:99–104.
  80. Kelly JD, Webster JH, Griffin DL, Whitlock HV, Martin ICA, Gunawan M. Resistance to benzimidazole anthelmintics in equine strongyles.. Aust Vet J 1981;57:163–171.
  81. Morris LH, Colgan S, Leathwick DM, Nielsen MK. Anthelmintic efficacy of single active and combination products against commonly occurring parasites in foals.. Vet Parasitol 2019;268:46–52.
  82. Wilkes E, McConaghy F, Thompson R, Dawson K, Sangster N, Hughes K. Efficacy of a morantel–abamectin combination for the treatment of resistant ascarids in foals.. Aust Vet J 2017;95:85–88.
  83. Leathwick DM, Sauermann CW, Geurden T, Nielsen MK. Managing anthelmintic resistance in Parascaris spp.: a modelling exercise.. Vet Parasitol 2017;240:75–81.
  84. Laugier C, Sevin C, Ménard S, Maillard K. Prevalence of Parascaris equorum infection in foals on French stud farms and first report of ivermectin‐resistant P. Equorum populations in France.. Vet Parasitol 2012;188:185–189.
  85. Armstrong SK, Woodgate RG, Gough S, Heller J, Sangster NC, Hughes KJ. The efficacy of ivermectin, pyrantel and fenbendazole against Parascaris equorum infection in foals on farms in Australia.. Vet Parasitol 2014;205:575–580.
  86. Sallé G, Guillot J, Tapprest J, Foucher N, Sevin C, Laugier C. Compilation of 29 years of postmortem examinations identifies major shifts in equine parasite prevalence from 2000 onwards.. Int J Parasitol 2020;50:125–132.
  87. Dunsmore JD, Jue Sue LP. Prevalence and epidemiology of the major gastrointestinal parasites of horses in Perth, Western Australia.. Equine Vet J 1985;17:208–213.
  88. Lyons ET, Swerczek TW, Tolliver SC, Bair HD, Drudge JH, Ennis LE. Prevalence of selected species of internal parasites in equids at necropsy in Central Kentucky (1995–1999).. Vet Parasitol 2000;92:51–62.
  89. Tolliver SC, Lyons ET, Drudge JH. Prevalence of internal parasites in horses in critical tests of activity of parasiticides over a 28‐year period (1956–1983) in Kentucky.. Vet Parasitol 1987;23:273–284.
  90. Arroyo LG, Quesada RJ, Medina‐Torres CE, Baird JD. What is your diagnosis? Ascarid impactions.. J Am Vet Med Assoc 2011;239:435–436.
  91. Cribb N, Coté N, Bouré L, Peregrine A. Acute small intestinal obstruction associated with Parascaris equorum infection in young horses: 25 cases (1985–2004).. N Z Vet J 2006;54:338–343.
  92. Tatz AJ, Segev G, Steinman A, Berlin D, Milgram J, Kelmer G. Surgical treatment for acute small intestinal obstruction caused by Parascaris equorum infection in 15 horses (2002‐2011).. Equine Vet J 2012;44:111–114.
  93. Vatistas NJ, Snyder JR, Wilson WD, Drake C, Hildebrand S. Surgical treatment for colic in the foal (67 cases): 1980‐1992.. Equine Vet J 1996;28(139):145.
  94. Cable C, Fubini S, Erb H, Hakes J. Abdominal surgery in foals: a review of 119 cases (1977–1994).. Equine Vet J 1997;29:257–261.
  95. Brown PJ, Clayton HM. Hepatic pathology of experimental Parascaris equorum infection in worm‐free foals.. J Comp Pathol 1979;89:115–123.
  96. Clayton HM, Duncan JL. Experimental Parascaris equorum infection of foals.. Res Vet Sci 1977;23:109–114.
  97. Clayton HM, Duncan JL. The migration and development of Parascaris equorum in the horse.. Int J Parasitol 1979;9:285–292.
  98. Clayton HM, Duncan JL, Dargie JD. Pathophysiological changes associated with Parascaris equorum infection in the foal.. Equine Vet J 1980;12:23–25.
  99. Bellaw JL, Pagan J, Cadell S, Phethean E, Donecker JM, Nielsen MK. Objective evaluation of two deworming regimens in young thoroughbreds using average daily gain, body condition score, and parasitological parameters.. J Equine Vet 2016;39:S49–S50.
  100. Nielsen MK, Gee EK, Hansen A, Waghorn T, Bell J, Leathwick DM. Monitoring equine ascarid and cyathostomin parasites: evaluating health parameters under different treatment regimens.. Equine Vet J 2021;53:902–910.
  101. Yoseph S, Smith DG, Mengistu A, Teklu F, Firew T, Betere Y. Seasonal variation in the parasite burden and body condition of working donkeys in east Shewa and West Shewa regions of Ethiopia.. Tropl Anim Health Prod 2005;37:35–45.
  102. Wilkes EJA, Cowling A, Woodgate RG, Hughes KJ. Inhomogeneity of the density of Parascaris spp. eggs in faeces of individual foals and the use of hypothesis testing for treatment decision making.. Vet Parasitol 2016;229:131–138.
  103. Wilkes EJA, Woodgate RG, Raidal SL, Hughes KJ. The application of faecal egg count results and statistical inference for clinical decision making in foals.. Vet Parasitol 2019;270:7–12.
  104. Nielsen MK, Donoghue EM, Stephens ML, Stowe CJ, Donecker JM, Fenger CK. An ultrasonographic scoring method for transabdominal monitoring of ascarid burdens in foals.. Equine Vet J 2016;48:380–386.
  105. Rehbein S, Visser M, Winter R. Prevalence, intensity and seasonality of gastrointestinal parasites in abattoir horses in Germany.. Parasitol Res 2013;112:407–413.
  106. Fabiani JV, Lyons ET, Nielsen MK. Dynamics of Parascaris and Strongylus spp. parasites in untreated juvenile horses.. Vet Parasitol 2016;230:62–66.
  107. Donoghue EM, Lyons ET, Bellaw JL, Nielsen MK. Biphasic appearance of corticated and decorticated ascarid egg shedding in untreated horse foals.. Vet Parasitol 2015;214:114–117.
  108. Slusarewicz P, Pagano S, Mills C, Popa G, Chow KM, Mendenhall M. Automated parasite fecal egg counting using fluorescence labeling, smartphone image capture and computational image analysis.. Int J Parasitol 2016;46(8):485–493.
  109. Burk SV, Dangoudoubiyam S, Brewster‐Barnes T, Howe DK, Carter CN, Bryant UK. Equine antibody response to larval Parascaris equorum excretory‐secretory products.. Vet Parasitol 2016;226:83–87.
  110. Burk SV, Dangoudoubiyam S, Brewster‐Barnes T, Bryant UK, Howe DK, Carter CN. In vitro culture of Parascaris equorum larvae and initial investigation of parasite excretory‐secretory products.. Parasitol Res 2014;113:4217–4224.
  111. Janssen IJI, Krücken J, Demeler J, Basiaga M, Kornaś S, von Samson‐Himmelstjerna G. Genetic variants and increased expression of Parascaris equorum P‐glycoprotein‐11 in populations with decreased ivermectin susceptibility.. PloS One 2013;8:e61635.
  112. Relf VE, Morgan ER, Hodgkinson JE, Matthews JB. A questionnaire study on parasite control practices on UK breeding thoroughbred studs.. Equine Vet J 2011;44:466–471.
  113. Wilkes EJA, Heller J, Raidal SL, Woodgate RG, Hughes KJ. A questionnaire study of parasite control in thoroughbred and Standardbred horses in Australia.. Equine Vet J 2020;52:547–555.
  114. Boersema JH, Eysker M, Nas JWM. Apparent resistance of Parascaris equorum to macrocylic lactones.. Vet Rec 2002;150:279.
  115. Lindgren K, Ljungvall Ö, Nilsson O, Ljungström B‐L, Lindahl C, Höglund J. Parascaris equorum in foals and in their environment on a Swedish stud farm, with notes on treatment failure of ivermectin.. Vet Parasitol 2008;151:337–343.
  116. Näreaho A, Vainio K, Oksanen A. Impaired efficacy of ivermectin against Parascaris equorum, and both ivermectin and pyrantel against strongyle infections in trotter foals in Finland.. Vet Parasitol 2011;182:372–377.
  117. Veronesi F, Moretta I, Moretti A, Fioretti DP, Genchi C. Field effectiveness of pyrantel and failure of Parascaris equorum egg count reduction following ivermectin treatment in Italian horse farms.. Vet Parasitol 2009;161:138–141.
  118. von Samson‐Himmelstjerna G, Fritzen B, Demeler J, Schürmann S, Rohn K, Schnieder T. Cases of reduced cyathostomin egg‐reappearance period and failure of Parascaris equorum egg count reduction following ivermectin treatment as well as survey on pyrantel efficacy on German horse farms.. Vet Parasitol 2007;144:74–80.
  119. Schougaard H, Nielsen MK. Apparent ivermectin resistance of Parascaris equorum in foals in Denmark.. Vet Rec 2007;160:439.
  120. Hearn FPD, Peregrine AS. Identification of foals infected with Parascaris equorum apparently resistant to ivermectin.. J Am Vet Med Assoc 2003;223:482–485.
  121. Reinemeyer CR, Prado JC, Nichols EC, Marchiondo AA. Efficacy of pyrantel pamoate against a macrocyclic lactone‐resistant isolate of Parascaris equorum in horses.. Vet Parasitol 2010;171:111–115.
  122. Slocombe JOD, de Gannes RVG, Lake MC. Macrocyclic lactone‐resistant Parascaris equorum on stud farms in Canada and effectiveness of fenbendazole and pyrantel pamoate.. Vet Parasitol 2007;145:371–376.
  123. Bishop R, Scott I, Gee E, Rogers C, Pomroy W, Mayhew I. Sub‐optimal efficacy of ivermectin against Parascaris equorum in foals on three thoroughbred stud farms in the Manawatu region of New Zealand.. New Zeal Vet J 2014;62:91–95.
  124. Larsen ML, Ritz C, Petersen SL, Nielsen MK. Determination of ivermectin efficacy against cyathostomins and Parascaris equorum on horse farms using selective therapy.. Vet J 2011;188:44–47.
  125. Veronesi F, Fioretti DP, Genchi C. Are macrocyclic lactones useful drugs for the treatment of Parascaris equorum infections in foals?. Vet Parasitol 2010;172:164–167.
  126. Austin SM, DiPietro JA, Foreman JH, Baker GJ, Todd KS. Comparison of the efficacy of ivermectin, oxibendazole, and pyrantel pamoate against 28‐day Parascaris equorum larvae in the intestine of pony foals.. J Am Vet Med Assoc 1991;198:1946–1949.
  127. Robert M, Hu W, Nielsen MK, Stowe CJ. Attitudes towards implementation of surveillance‐based parasite control on Kentucky thoroughbred farms – current strategies, awareness and willingness‐to‐pay.. Equine Vet J 2015;47:694–700.
  128. Leathwick DM, Sauermann CW, Donecker JM, Nielsen MK. A model for the development and growth of the parasitic stages of Parascaris spp. in the horse.. Vet Parasitol 2016;228:108–115.
  129. Relf VE, Lester HE, Morgan ER, Hodgkinson JE, Matthews JB. Anthelmintic efficacy on UK thoroughbred stud farms.. Int J Parasitol 2014;44:507–514.
  130. Martin F, Höglund J, Bergström TF, Lindsjö OK, Tydén E. Resistance to pyrantel embonate and efficacy of fenbendazole in Parascaris univalens on Swedish stud farms.. Vet Parasitol 2018;264:69–73.
  131. Lyons ET, Dorton AR, Tolliver SC. Evaluation of activity of fenbendazole, oxibendazole, piperazine, and pyrantel pamoate alone and combinations against ascarids, strongyles, and strongyloides in horse foals in field tests on two farms in Central Kentucky in 2014 and 2015.. Vet Parasitol Reg Stud Rep 2016;3:23–26.
  132. Lyons ET, Tolliver SC, Kuzmina TA, Collins SS. Further evaluation in field tests of the activity of three anthelmintics (fenbendazole, oxibendazole, and pyrantel pamoate) against the ascarid Parascaris equorum in horse foals on eight farms in Central Kentucky (2009–2010).. Parasitol Res 2011;109:1193–1197.
  133. DiPietro JA, Lock TF, Todd KS, Sanecki RK. Evaluation of ivermectin for larvicidal effect in experimentally induced Parascaris equorum infections in pony foals.. Am J Vet Res 1988;49:1983–1985.
  134. French DD, Klei TR, Taylor HW, Chapman MR. Efficacy of ivermectin in oral drench and paste formulation against migrating larvae of experimentally inoculated Parascaris equorum.. Am J Vet Res 1989;50:1071–1073.
  135. French DD, Klei TR, Taylor HW, Chapman MR, Wright FR. Efficacy of ivermectin in the oral paste formulation against naturally acquired adult and larval stages of Parascaris equorum in pony foals.. Am J Vet Res 1988;49:1000–1003.
  136. DiPietro JA, Lock TF, Todd KS, Davis JL. Efficacy of ivermectin in the treatment of induced Parascaris equorum infection in pony foals.. J Am Vet Med Assoc 1989;195:1712–1714.
  137. Vandermyde CR, DiPietro JA, Todd KS, Lock TF. Evaluation of fenbendazole for larvacidal effect in experimentally induced Parascaris equorum infections in pony foals.. J Am Vet Med Assoc 1987;190:1548–1549.
  138. Hébert L, Cauchard J, Doligez P, Quitard L, Laugier C, Petry S. Viability of Rhodococcus equi and Parascaris equorum eggs exposed to high temperatures.. Curr Microbiol 2010;60:38–41.
  139. Koudela B, Bodeček Š. Effects of low and high temperatures on viability of Parascaris equorum eggs suspended in water.. Vet Parasitol 2006;142:123–128.
  140. Gould JC, Rossano MG, Lawrence LM, Burk SV, Ennis RB, Lyons ET. The effects of windrow composting on the viability of Parascaris equorum eggs.. Vet Parasitol 2013;191:73–80.
  141. Fischer JK, Hinney B, Denwood MJ, Traversa D, von Samson‐Himmelstjerna G, Clausen P‐H. Efficacy of selected anthelmintic drugs against cyathostomins in horses in the federal state of Brandenburg, Germany.. Parasitol Res 2015;114:4441–4450.
  142. Stratford CH, Lester HE, Pickles KJ, McGorum BC, Matthews JB. An investigation of anthelmintic efficacy against strongyles on equine yards in Scotland.. Equine Vet J 2014;46:17–24.
  143. Lester HE, Spanton J, Stratford CH, Bartley DJ, Morgan ER, Hodgkinson JE. Anthelmintic efficacy against cyathostomins in horses in southern England.. Vet Parasitol 2013;197:189–196.
  144. Bellaw JL, Krebs K, Reinemeyer CR, Norris JK, Scare JA, Pagano S. Anthelmintic therapy of equine cyathostomin nematodes – larvicidal efficacy, 146 reappearance period, and drug resistance.. Int J Parasitol 2018;48:97–105.
  145. Reinemeyer CR, Prado JC, Nielsen MK. Comparison of the larvicidal efficacies of moxidectin or a five‐day regimen of fenbendazole in horses harboring cyathostomin populations resistant to the adulticidal dosage of fenbendazole.. Vet Parasitol 2015;214:100–107.
  146. Duncan JL, Bairden K, Abbott EM. Elimination of mucosal cyathostome larvae by five daily treatments with fenbendazole.. Vet Rec 1998;142:268.
  147. Tzelos T, Barbeito JSG, Nielsen MK, Morgan ER, Hodgkinson JE, Matthews JB. Strongyle egg reappearance period after moxidectin treatment and its relationship with management factors in UK equine populations.. Vet Parasitol 2017;237:70–76.
  148. Molena RA, Peachey LE, di Cesare A, Traversa D, Cantacessi C. Cyathostomine egg reappearance period following ivermectin treatment in a cohort of UK thoroughbreds.. Parasite Vector 2018;11:61.
  149. Lyons ET, Tolliver SC, Kuzmina TA, Collins SS. Critical tests evaluating efficacy of moxidectin against small strongyles in horses from a herd for which reduced activity had been found in field tests in Central Kentucky.. Parasitol Res 2010;107:1495–1498.
  150. Rossano MG, Smith AR, Lyons ET. Shortened strongyle‐type egg reappearance periods in naturally infected horses treated with moxidectin and failure of a larvicidal dose of fenbendazole to reduce fecal egg counts.. Vet Parasitol 2010;173:349–352.
  151. Nielsen MK, Steuer AE, Anderson HP, Gavriliuc S, Carpenter AB, Redman EM. Shortened egg reappearance periods of equine cyathostomins following ivermectin or moxidectin treatment: morphological and molecular investigation of efficacy and species composition.. Int J Parasitol 2022;52:787–798.
  152. Bull KE, Allen KJ, Hodgkinson JE, Peachey LE. The first report of macrocyclic lactone resistant cyathostomins in the UK.. Int J Parasitol Drugs Drug Resist 2023;21:125–130.
  153. Abbas G, Ghafar A, Hurley J, Bauquier J, Beasley A, Wilkes EJA. Cyathostomin resistance to moxidectin and combinations of anthelmintics in Australian horses.. Parasite Vector 2021;14:597.
  154. Xiao L, Herd RP, Majewski GA. Comparative efficacy of moxidectin and ivermectin against hypobiotic and encysted cyathostomes and other equine parasites.. Vet Parasitol 1994;53:83–90.
  155. Bauer C, Çirak VY, Hermosilla C, Okoro H. Efficacy of a 2 per cent moxidectin gel against gastrointestinal parasites of ponies.. Vet Rec 1998;143:558.
  156. Bello TR, Laningham JET. A controlled trial evaluation of three oral dosages of moxidectin against equine parasites.. J Equine Vet 1994;14:483–488.
  157. Sanna G, Pipia AP, Tamponi C, Manca R, Varcasia A, Traversa D. Anthelmintics efficacy against intestinal strongyles in horses of Sardinia, Italy.. Parasite Epidemiol Control 2016;1:15–19.
  158. Traversa D, Castagna G, von Samson‐Himmelstjerna G, Meloni S, Bartolini R, Geurden T. Efficacy of major anthelmintics against horse cyathostomins in France.. Vet Parasitol 2012;188:294–300.
  159. Geurden T, van Doorn D, Claerebout E, Kooyman F, Keersmaecker SD, Vercruysse J. (2014) decreased strongyle egg re‐appearance period after treatment with ivermectin and moxidectin in horses in Belgioum, Italy and The Netherlands.. Vet Parasitol 2014;204:291–296.
  160. Dauparaitė E, Kupčinskas T, Varady M, Petkevičius S. Anthelmintic resistance of horse strongyle nematodes to fenbendazole in Lithuania.. Acta Vet Scand 2022;64:26.
  161. Eysker M, Boersema JH, Kooyman FNJ. Effect of early season ivermectin and pyrantel treatments on strongylid infections in young Shetland ponies in The Netherlands.. Vet Parasitol 1991;38:33–39.
  162. Vidyashankar AN, Hanlon BM, Kaplan RM. Statistical and biological considerations in evaluating drug efficacy in equine strongyle parasites using fecal egg count data.. Vet Parasitol 2012;185:45–56.
  163. Coles GC, Bauer C, Borgsteede FHM, Geerts S, Klei TR, Taylor MA. World Association for the Advancement of veterinary parasitology (W.A.A.V.P.) methods for the detection of anthelmintic resistance in nematodes of veterinary importance.. Vet Parasitol 1992;44:35–44.
  164. Slocombe JO, Smart J. Evaluation of pyrantel pamoate against strongyles in horses.. Can Vet J 1975;16:310–312.
  165. Colglazier ML, Enzie FD, Kates KC. Critical anthelmintic trials in ponies with four benzimidazoles: mebendazole, cambendazole, fenbendazole, and albendazole.. J Parasitol 1977;63:724–727.
  166. Valdez RA, DiPietro JA, Paul AJ, Lock TF, Hungerford LL, Todd KS. Controlled efficacy study of the bioequivalence of strongid® C and generic pyrantel tartrate in horses.. Vet Parasitol 1995;60:83–102.
  167. Burger H, Bauer C. Efficacy of four anthelmintics against benzimidazole‐resistant cyathostomes of horses.. Vet Rec 1987;120:293.
  168. Lumsden GG, Quan‐Taylor R, Smith SM, Washbrooke IM. Field efficacy of ivermectin, fenbendazole and pyrantel embonate paste anthelmintics in horses.. Vet Rec 1989;125:497–499.
  169. Slocombe JO, Cote JF. Effectiveness of ivermectin paste for removal of nematodes in the horse.. Can Vet J 1984;25:386–388.
  170. Boersema JH, Eysker M, Maas J, van der Aar WM. Comparison of the reappearance of strongyle eggs in foals, yearlings, and adult horses after treatment with ivermectin or pyrantel.. Vet Q 1996;18:7–9.
  171. Borgsteede FH, Boersma JH, Gaasenbeek CP, van der Burg WP. The reappearance of eggs in faeces of horses after treatment with ivermectin.. Vet Q 1993;15:24–26.
  172. Klei TR, Chapman MR, French DD, Taylor HW. Evaluation of ivermectin at an elevated dose against encysted equine cyathostome larvae.. Vet Parasitol 1993;47:99–106.
  173. Boersema JH, Eysker M, van der Aar WM. The reappearance of strongyle eggs in the faeces of horses after treatment with moxidectin.. Vet Q 1998;20:15–17.
  174. Rolfe P, Dawson K, Holm‐Martin M. Efficacy of moxidectin and other anthelmintics against small strongyles in horses.. Aust Vet J 1998;76:332–334.
  175. Demeulenaere D, Vercruysse J, Dorny P, Claerebout E. Comparative studies of ivermectin and moxidectin in the control of naturally acquired cyathostome infections in horses.. Vet Rec 1997;141:383.
  176. Giles CJ, Urquhart KA, Longstaffe JA. Larval cyathostomiasis (immature trichonema‐induced enteropathy): a report of 15 clinical cases.. Equine Vet J 1985;17:196–201.
  177. Mair T. Outbreak of larval cyathostomiasis among a group of yearling and two‐year‐old horses.. Vet Rec 1994;135:598.
  178. Mair TS, Pearson GR. Multifocal non‐strangulating intestinal infarction associated with larval cyathostomiasis in a pony.. Equine Vet J 1995;27:154–155.
  179. Mair TS, Sutton DG, Love S. Caecocaecal and caecocolic intussusceptions associated with larval cyathostomosis in four young horses.. Equine Vet J 2000;32(S32):77–80.
  180. Peregrine AS, McEwen B, Bienzle D, Koch TG, Weese JS. Larval cyathostominosis in horses in Ontario: an emerging disease?. Can Vet J 2006;47:80–82.
  181. Hodgkinson JE, Lichtenfels JR, Mair TS, Cripps P, Freeman KL, Ramsey YH. A PCR–ELISA for the identification of cyathostomin fourth‐stage larvae from clinical cases of larval cyathostominosis.. Int J Parasitol 2003;33:1427–1435.
  182. Wobeser G, Tataryn A. Cyathostominosis in a horse from Saskatchewan.. Can Vet J 2009;50:1099–1100.
  183. Walshe N, Mulcahy G, Crispie F, Cabrera‐Rubio R, Cotter P, Jahns H. Outbreak of acute larval cyathostominosis – a “perfect storm” of inflammation and dysbiosis.. Equine Vet J 2021;53:727–739.
  184. Reid SWJ, Mair TS, Hillyer MH, Love S. Epidemiological risk factors associated with a diagnosis of clinical cyathostomiasis in the horse.. Equine Vet J 1995;27:127–130.
  185. Smets K, Shaw DJ, Deprez P, Vercruysse J. Diagnosis of larval cyathostominosis in horses in Belgium.. Vet Rec 1999;144:665–668.
  186. Zakrajsek E. Unusual presentation of cyathostomiasis in an adult thoroughbred mare.. Can Vet J 2017;58:1221–1223.
  187. Mair TS. Recurrent diarrhoea in aged ponies associated with larval cyathostomiasis.. Equine Vet J 1993;25:161–163.
  188. Loon G, Deprez P, Muylle E, Sustronck B. Larval cyathostomiasis as a cause of death in two regularly dewormed horses.. J Vet Med Ser A 1995;42:301–306.
  189. Tzelos T, Geyer KK, Mitchell MC, McWilliam HEG, Kharchenko VO, Burgess STG. (2020) characterisation of serum IgG(T) responses to potential diagnostic antigens for equine cyathostominosis.. Int J Parasitol 2020;50:289–298.
  190. Lightbody KL, Austin A, Lambert PA, von Samson‐Himmelstjerna G, Jürgenschellert L, Krücken J. Validation of a serum ELISA test for cyathostomin infection in equines.. Int J Parasitol 2023.
    doi: 10.1016/j.ijpara.2023.07.001google scholar: lookup
  191. Bellaw JL, Nielsen MK. Meta‐analysis of cyathostomin species‐specific prevalence and relative abundance in domestic horses from 1975–2020: emphasis on geographical region and specimen collection method.. Parasite Vector 2020;13:509.
  192. Höglund J, Ljungström B‐L, Nilsson O, Uggla A. Enzyme‐linked immunosorbent assay (ELISA) for the detection of antibodies to Anoplocephala perfoliata in horse sera.. Vet Parasitol 1995;59:97–106.
  193. Proudman CJ, Trees AJ. Use of excretory/secretory antigens for the serodiagnosis of Anoplocephala perfoliata cestodosis.. Vet Parasitol 1996;61:239–247.
  194. Proudman CJ, Trees AJ. Correlation of antigen specific IgG and IgG(T) responses with Anoplocephala perfoliata infection intensity in the horse.. Parasite Immunol 1996;18:499–506.
  195. Kjaer LN, Lungholt MM, Nielsen MK, Olsen SN, Maddox‐Hyttel C. Interpretation of serum antibody response to Anoplocephala perfoliata in relation to parasite burden and faecal egg count.. Equine Vet J 2007;39:529–533.
  196. Morgan ER, Hetzel N, Povah C, Coles GC. Prevalence and diagnosis of parasites of the stomach and small intestine in horses in south‐West England.. Vet Rec 2005;156:597–600.
  197. Slocombe JO. Prevalence and treatment of tapeworms in horses.. Can Vet J 1979;20:136–140.
  198. Nilsson O, Ljungström B‐L, Höglund J, Lundquist H, Uggla A. Anoplocephala perfoliata in horses in Sweden: prevalence, infection levels and intestinal lesions.. Acta Vet Scand 1995;36:319–328.
  199. Meana A, Luzon M, Corchero J, Gómez‐Bautista M. Reliability of coprological diagnosis of Anoplocephala perfoliata infection.. Vet Parasitol 1998;74:79–83.
  200. Williamson R, Beveridge I, Gasser R. Coprological methods for the diagnosis of Anoplocephala perfoliata infection of the horse.. Aust Vet J 1998;76:618–621.
  201. Tomczuk K, Kostro K, Szczepaniak KO, Grzybek M, Studzińska M, Demkowska‐Kutrzepa M. Comparison of the sensitivity of coprological methods in detecting Anoplocephala perfoliata invasions.. Parasitol Res 2014;113:2401–2406.
  202. Proudman C, Edwards G. Validation of a centrifugation/flotation technique for the diagnosis of equine cestodiasis.. Vet Rec 1992;131:71.
  203. Lightbody KL, Davis PJ, Austin CJ. Validation of a novel saliva‐based ELISA test for diagnosing tapeworm burden in horses.. Vet Clin Pathol 2016;45:335–346.
  204. Lightbody KL, Matthews JB, Kemp‐Symonds JG, Lambert PA, Austin CJ. Use of a saliva‐based diagnostic test to identify tapeworm infection in horses in the UK.. Equine Vet J 2017;50:213–219.
  205. Drogemuller M, Beelitz P, Pfister K, Schnieder T, von Samson‐Himmelstjerna G. Amplification of ribosomal DNA of Anoplocephalidae: Anoplocephala perfoliata diagnosis by PCR as a possible alternative to coprological methods.. Vet Parasitol 2004;124:205–215.
  206. Kania SA, Reinemeyer CR. Anoplocephala perfoliata coproantigen detection: a preliminary study.. Vet Parasitol 2005;127:115–119.
  207. Traversa D, Fichi G, Campigli M, Rondolotti A, Iorio R, Proudman CJ. A comparison of coprological, serological and molecular methods for the diagnosis of horse infection with Anoplocephala perfoliata (Cestoda, Cyclophyllidea).. Vet Parasitol 2008;152:271–277.
  208. Skotarek SL, Colwell DD, Goater CP. Evaluation of diagnostic techniques for Anoplocephala perfoliata in horses from Alberta, Canada.. Vet Parasitol 2010;172:249–255.
  209. Fogarty U, del Piero F, Purnell R, Mosurski K. Incidence of Anoplocephala perfoliata in horses examined at an Irish abattoir.. Vet Rec 1994;134:515.
  210. Pittaway CE, Lawson AL, Coles GC, Wilson AD. Systemic and mucosal IgE antibody responses of horses to infection with Anoplocephala perfoliata.. Vet Parasitol 2014;199:32–41.
  211. Ihler CF, Rootwelt V, Heyeraas A, Dolvik NJ. The prevalence and epidemiology of Anoplocephala perfoliata infection in Norway.. Vet Res Commun 1995;19:487–494.
  212. Pearson G, Davies L, White A, O'Brien J. Pathological lesions associated with Anoplocephala perfoliata at the ileo‐caecal junction of horses.. Vet Rec 1993;132:179.
  213. Boswinkel M, van Oldruitenborgh‐Oosterbaan MMS. Correlation between colic and antibody levels against Anoplocephala perfoliata in horses in The Netherlands.. Tijdschr Diergeneesk 2007;132:508–512.
  214. Proudman CJ, French NP, Trees AJ. Tapeworm infection is a significant risk factor for spasmodic colic and ileal impaction colic in the horse.. Equine Vet J 1998;30:194–199.
  215. Meana A, Pato NF, Martín R, Mateos A, Pérez‐García J, Luzón M. Epidemiological studies on equine cestodes in Central Spain: infection pattern and population dynamics.. Vet Parasitol 2005;130:233–240.
  216. Höglund J, Nilsson O, Ljungström B‐L, Hellander J, Lind EO, Uggla A. Epidemiology of Anoplocephala perfoliata infection in foals on a stud farm in South‐Western Sweden.. Vet Parasitol 1998;75:71–79.
  217. Hreinsdttir I, Hreinsdttir A, Eydal M, Tysnes KR, Robertson LJ. Anoplocephala perfoliata infection in horses in Iceland: investigation of associations between intensity of infection and lesions.. J Parasitol 2019;105:379–386.
  218. Trotz‐Williams L, Physick‐Sheard P, McFarlane H, Pearl DL, Martin SW, Peregrine AS. Occurrence of Anoplocephala perfoliata infection in horses in Ontario, Canada and associations with colic and management practices.. Vet Parasitol 2008;153:73–84.
  219. Jürgenschellert L, Krücken J, Austin CJ, Lightbody KL, Bousquet E, von Samson‐Himmelstjerna G. Investigations on the occurrence of tapeworm infections in German horse populations with comparison of different antibody detection methods based on saliva and serum samples.. Parasite Vector 2020;13:462.
  220. Engell‐Sørensen K, Pall A, Damgaard C, Holmstrup M. Seasonal variation in the prevalence of equine tapeworms using coprological diagnosis during a seven‐year period in Denmark.. Vet Parasitol Reg Stud Rep 2018;12:22–25.
  221. Proudman CJ, Holdstock NB. Investigation of an outbreak of tapeworm‐associated colic in a training yard.. Equine Vet J 2000;32:37–41.
  222. Reeves MJ, Salman MD, Smith G. Risk factors for equine acute abdominal disease (colic): results from a multi‐center case‐control study.. Prev Vet Med 1996;26:285–301.
  223. Grubbs ST, Amodie D, Rulli D, Wulster‐Radcliffe M, Reinemeyer C, Yazwinski T. Field evaluation of moxidectin/praziquantel oral gel in horses.. Vet Ther 2003;4:249–256.
  224. Marchiondo AA, White GW, Smith LL, Reinemeyer CR, Dascanio JJ, Johnson EG. Clinical field efficacy and safety of pyrantel pamoate paste (19.13% w/w pyrantel base) against Anoplocephala spp. in naturally infected horses.. Vet Parasitol 2006;137:94–102.
  225. Roelfstra L, Betschart B, Pfister K. A study on the seasonal epidemiology of Anoplocephala spp.‐infection in horses and the appropriate treatment using a praziquantel gel (Droncit 9% oral gel).. Berl Munch Tierarztl 2006;119:312–315.
  226. Slocombe JOD, Heine J, Barutzki D, Slacek B. Clinical trials of efficacy of praziquantel horse paste 9% against tapeworms and its safety in horses.. Vet Parasitol 2007;144:366–370.
  227. Slocombe JOD. A modified critical test and its use in two dose titration trials to assess efficacy of praziquantel for Anoplocephala perfoliata in equids.. Vet Parasitol 2006;136:127–135.
  228. Slocombe JOD. A modified critical test for the efficacy of pyrantel pamoate for Anoplocephala perfoliata in equids.. Can J Vet Res 2004;68:112–117.
  229. Lyons ET, Drudge JH, Tolliver SC, Swerczek TW, Collins SS. Determination of the efficacy of pyrantel pamoate at the therapeutic dose rate against the tapeworm Anoplocephala perfoliata in equids using a modification of the critical test method.. Vet Parasitol 1989;31:13–18.
  230. Nielsen MK. Apparent treatment failure of praziquantel and pyrantel pamoate against anoplocephalid tapeworms.. Int J Parasitol Drugs Drug Resist 2023;22:96–101.
  231. Dawson K. A non‐lethal method for assessment of efficacy of antiparasitics against parasites in horses such as Anoplocephala perfoliata and Gasterophilus intestinalis.. Vet Parasitol 2003;115:67–70.
  232. Nansen P, Andersen S, Hesselholt M. Experimental infection of the horse with Fasciola hepatica.. Exp Parasitol 1975;37:15–19.
  233. Boray JC. Experimental fascioliasis in Australia.. Adv Parasitol 1969;7:95–210.
  234. Quigley A, Sekiya M, Garcia‐Campos A, Paz‐Silva A, Howell A, Williams DJL. Horses are susceptible to natural, but resistant to experimental, infection with the liver fluke, Fasciola hepatica.. Vet Parasitol 2020;281:109094.
  235. Donat F, Lahitte JD, Braun JP, Thouvenot JP, Krahe B, Dorchies P. Biochemical and haematological changes observed in ponies with experimental Fasciola hepatica infection.. Rev Med Vét 1990;141:557–563.
  236. Dorchies P, Lahitte JD, Donat F. Treatment of experimental fascioliasis in horses with closantel.. Rev Med Vet 1990;141:383–387.
  237. Soulé C, Boulard C, Levieux D, Barnouin J, Plateau E. Experimental equine fascioliasis: evolution of serologic, enzymatic and parasitic parameters.. Ann Vet Res 1989;20:295–307.
  238. Grelck H, Hörchner F, Wöhrl H. Experimental infection of horses with Fasciola hepatica.. Berl Munch Tierarztl 1977;90:371–373.
  239. Owen JM. Liver fluke infection in horses and ponies.. Equine Vet J 1977;9:29–31.
  240. Sadzikowski AB, Studziñska MB, Tomczuk K, Demkowska M. Fasciola hepatica invasion in horses from central and eastern Poland.. Med Weter 2009;65:707–709.
  241. Arias MS, Piñeiro P, Hillyer GV, Francisco I, Cazapal‐Monteiro CF, Suárez JL. Enzyme‐linked immunosorbent assays for the detection of equine antibodies specific to a recombinant Fasciola hepatica surface antigen in an endemic area.. Parasitol Res 2012;110:1001–1007.
  242. Quigley A, Sekiya M, Egan S, Wolfe A, Negredo C, Mulcahy G. Prevalence of liver fluke infection in Irish horses and assessment of a serological test for diagnosis of equine fasciolosis.. Equine Vet J 2017;49:183–188.
  243. Howell AK, Malalana F, Beesley NJ, Hodgkinson JE, Rhodes H, Sekiya M. Fasciola hepatica in UK horses.. Equine Vet J 2020;52:194–199.
  244. Raftery AG, Berman KG, Sutton DGM. Severe eosinophilic cholangiohepatitis due to fluke infestation in a pony in Scotland.. Equine Vet Educ 2017;29:196–201.
  245. Palmer DG, Lyon J, Palmer MA, Forshaw D. Evaluation of a copro‐antigen ELISA to detect Fasciola hepatica infection in sheep, cattle and horses.. Aust Vet J 2014;92:357–361.
  246. Gorman T, Aballay J, Fredes F, Silva M, Aguillón JC, Alcaíno HA. Immunodiagnosis of fasciolosis in horses and pigs using Western blots.. Int J Parasitol 1997;27:1429–1432.
  247. Acici M, Bolukbas CS, Gurler AT, Umur S, Buyuktanir O. Seroprevalence of fasciolosis in equines of the Black Sea region, Turkey.. J Equine Vet 2013;33:62–66.
  248. Campe J, Vyt P, Duchene K. Leverbot op een Belgische stoeterij.. Vlaams Diergeneeskd Tijdschr 2011;80:403–406.
  249. Kiermayer I. Natural Fasciola hepatica infections in horses with consideration of chemotherapy under enzymatic and serological control.. PhD Thesis 1990.
  250. Rubilar L, Cabreira A, Giacaman L. Treatment of Fasciola hepatica infection in horses with triclabendazole.. Vet Rec 1988;123:320.
  251. Holtmann W, Ising S, Stoye M. Efficacy of triclabendazole against experimental infestation of horses with Fasciola hepatica.. Tierarztl Umsch 1990;45:437–438.
  252. Kamaludeen J, Graham‐Brown J, Stephens N, Miller J, Howell A, Beesley NJ. Lack of efficacy of triclabendazole against Fasciola hepatica is present on sheep farms in three regions of England, and Wales.. Vet Rec 2019;184:502.
  253. Vibe‐Petersen G, Nielsen K. Verminous enteritis and thrombo‐embolic colic in the horse. A description of 36 cases.. Nord Vet Med 1979;31:385–391.
  254. DeLay J, Peregrine AS, Parsons DA. Verminous arteritis in a 3‐month‐old thoroughbred foal.. Can Vet J 2001;42:289–291.
  255. Duncan J. Strongylus vulgaris infection in the horse.. Vet Rec 1974;95:34.
  256. Duncan JL, Pirie HM. The pathogenesis of single experimental infections with Strongylus vulgaris in foals.. Res Vet Sci 1975;18:82–93.
  257. White NA, Moore JN, Douglas M. SEM study of Strongylus vulgaris larva‐induced arteritis in the pony.. Equine Vet J 1983;15:349–353.
  258. Berry CR, Merritt AM, Burrows CF, Campbell M, Drudge JH. Evaluation of the myoelectrical activity of the equine ileum infected with Strongylus vulgaris larvae.. Am J Vet Res 1986;47:27–30.
  259. Drudge JH. Clinical aspects of Strongylus vulgaris infection in the horse: emphasis on diagnosis, chemotherapy, and prophylaxis.. Vet Clin North Am Large Anim Pract 1979;1:251–265.
  260. Thamsborg SM, Leiffson PS, Grondahl C, Larsen M, Nansen P. Impact of mixed strongyle infections in foals after one month on pasture.. Equine Vet J 1998;30:240–245.
  261. Tydén E, Enemark HL, Franko MA, Höglund J, Osterman‐Lind E. Prevalence of Strongylus vulgaris in horses after ten years of prescription usage of anthelmintics in Sweden.. Vet Parasitol X 2019;2:100013.
  262. Gehlen H, Wulke N, Ertelt A, Nielsen MK, Morelli S, Traversa D. Comparative analysis of intestinal helminth infections in colic and non‐colic control equine patients.. Animals (Basel) 2020;10:1916.
  263. Nielsen MK, Jacobsen S, Olsen SN, Bousquet E, Pihl T. Nonstrangulating intestinal infarction associated with Strongylus vulgaris in referred Danish equine cases.. Equine Vet J 2015;48:376–379.
  264. Pihl TH, Nielsen MK, Olsen SN, Leifsson PS, Jacobsen S. Nonstrangulating intestinal infarctions associated with Strongylus vulgaris: clinical presentation and treatment outcomes of 30 horses (2008‐2016).. Equine Vet J 2018;50:474–480.
  265. Cain JL, Jarisch K, Macaluso KR, Luedtke BE. Correlation between fecal egg count, presence of Strongylus vulgaris, and body score of feral horses on fort Polk, Louisiana.. Vet Parasitol Reg Stud Rep 2018;13:14–17.
  266. Harvey AM, Meggiolaro MN, Hall E, Watts ET, Ramp D, Šlapeta J. Wild horse populations in south‐East Australia have a high prevalence of Strongylus vulgaris and may act as a reservoir of infection for domestic horses.. Int J Parasitol Parasites Wildl 2019;8:156–163.
  267. Lyons ET, Drudge JH, Swerczek TW, Crowe MW, Tolliver SC. Prevalence of Strongylus vulgaris and Parascaris equorum in Kentucky thoroughbreds at necropsy.. J Am Vet Med Assoc 1981;179:818–819.
  268. Bucknell DG, Gasser RB, Beveridge I. The prevalence and epidemiology of gastrointestinal parasites of horses in Victoria, Australia.. Int J Parasitol 1995;25:711–724.
  269. Ogbourne CP. Studies on the epidemiology of Strongylus vulgaris infection of the horse.. Int J Parasitol 1975;5:423–426.
  270. Lyons ET, Tolliver SC, Drudge JH, Swerczek TW, Crowe MW. Common internal parasites found in the stomach, large intestine, and cranial mesenteric artery of thoroughbreds in Kentucky at necropsy (1985 to 1986).. Am J Vet Res 1987;48:268–273.
  271. Gawor JJ. The prevalence and abundance of internal parasites in working horses autopsied in Poland.. Vet Parasitol 1995;58:99–108.
  272. Lyons ET, Tolliver SC, Stamper S, Drudge JH, Granstrom DE, Collins SS. Transmission of some species of internal parasites in horses born in 1990, 1991, and 1992 in the same pasture on a farm in Central Kentucky.. Vet Parasitol 1994;52:257–269.
  273. English AW. The epidemiology of equine strongylosis in southern Queensland 1. The bionomics of the free‐living stages in faeces and on pasture.. Aust Vet J 1979;55:299–305.
  274. Hinney B, Wirtherle NC, Kyule M, Miethe N, Zessin K‐H, Clausen P‐H. Prevalence of helminths in horses in the state of Brandenburg, Germany.. Parasitol Res 2011;108:1083.
  275. Vera JHS, Fachiolli DF, Ramires LM, de Saes IL, Yamada PH, Gonçalves JA. Eficacy of ivermectin, moxidectin and febendazole in equine in Brazil.. Vet Parasitol Reg Stud Rep 2020;20:100374.
  276. Lind EO, Hoglund J, Ljungstrom B‐L, Nilsson O, Uggla A. A field survey on the distribution of strongyle infections of horses in Sweden and factors affecting faecal egg counts.. Equine Vet J 1999;31:68–72.
  277. Schneider S, Pfister K, Becher AM, Scheuerle MC. Strongyle infections and parasitic control strategies in German horses – a risk assessment.. BMC Vet Res 2014;10:262.
  278. Nielsen MK, Olsen SN, Lyons ET, Monrad J, Thamsborg SM. Real‐time PCR evaluation of Strongylus vulgaris in horses on farms in Denmark and Central Kentucky.. Vet Parasitol 2012;190:1–6.
  279. Nielsen MK, Vidyashankar AN, Olsen SN, Monrad J, Thamsborg SM. Strongylus vulgaris associated with usage of selective therapy on Danish horse farms—is it reemerging?. Vet Parasitol 2012;189:260–266.
  280. Jenkins E, Backwell A‐L, Bellaw J, Colpitts J, Liboiron A, McRuer D. Not playing by the rules: unusual patterns in the epidemiology of parasites in a natural population of feral horses (Equus caballus) on Sable Island, Canada.. Int J Parasitol Parasites Wildl 2020;11:183–190.
  281. Hedberg‐Alm Y, Penell J, Riihimäki M, Osterman‐Lind E, Nielsen MK, Tydén E. Parasite occurrence and parasite management in Swedish horses presenting with gastrointestinal disease—a case–control study.. Animals (Basel) 2020;10:638.
  282. Pilo C, Altea A, Pirino S, Nicolussi P, Varcasia A, Genchi M. Strongylus vulgaris (Looss, 1900) in horses in Italy: is it still a problem?. Vet Parasitol 2012;184:161–167.
  283. Jürgenschellert L, Krücken J, Bousquet E, Bartz J, Heyer N, Nielsen MK. Occurrence of strongylid nematode parasites on horse farms in Berlin and Brandenburg, Germany, with high seroprevalence of Strongylus vulgaris infection.. Front Vet Sci 2022;9:892920.
  284. Poulsen L, Henriksson FV, Dahl M, Honoré ML, Olsen SN, Leifsson PS. Differentiating Strongylus vulgaris‐associated, non‐strangulating intestinal infarctions from idiopathic peritonitis and acute colitis in horses.. Vet Rec 2022;192:e2538.
  285. Wetzel R. On the biology of the fourth stage larva of Oxyuris equi (Schrank).. J Parasitol 1930;17:95–97.
  286. Wolf D, Hermosilla C, Taubert A. Oxyuris equi: lack of efficacy in treatment with macrocyclic lactones.. Vet Parasitol 2014;201:163–168.
  287. Tolliver SC, Swerczek TW, Lyons ET. Recovery of Oxyuris equi eggs from hemomelasma ilei lesions on ileal serosa of a thoroughbred yearling filly.. Vet Parasitol 1999;80:353–357.
  288. Joachim A, Riedl L, Riedelberger K, Hinney B, Cavalleri J‐M. Is Oxuris equi a winner in selective worming?. Der Praktische Tierarzt 2020;101:767–775.
  289. Lyons ET, Tolliver SC, Collins SS. Prevalence of large endoparasites at necropsy in horses infected with population B small strongyles in a herd established in Kentucky in 1966.. Parasitol Res 2006;99:114–118.
  290. Barros HL, Marques SMT, Stefani V. The use of epifluorescence microscopy and fluorescent dyes for visualization of Oxyuris equi eggs.. Vet Parasitol 2016;226:162–166.
  291. Durham A, Coles G. Possible resistance in equine pinworms.. Vet Rec 2010;167:913.
  292. Stephenson R. Oxyuris equi: a resurgent problem?. UK Vet 2010;15:8–10.
  293. Felippelli G, Cruz BC, Gomes LVC, Lopes WDZ, Teixeira WFP, Maciel WG. Susceptibility of helminth species from horses against different chemical compounds in Brazil.. Vet Parasitol 2015;212(3–4):232–238.
  294. Scháňková Š, Maršálek M, Wagnerová P, Lukešová D, Starostová L, Jankovská I. Treatment failure of ivermectin for Oxyuris equi in naturally infected ponies in Czech Republic.. Helminthologia 2013;50:232–234.
  295. Sallé G, Cortet J, Koch C, Gascogne T, Reigner F, Cabaret J. Ivermectin failure in the control of Oxyuris equi in a herd of ponies in France.. Vet Parasitol 2016;229:73–75.
  296. Reinemeyer CR, Prado JC, Nichols EC, Marchiondo AA. Efficacy of pyrantel pamoate and ivermectin paste formulations against naturally acquired Oxyuris equi infections in horses.. Vet Parasitol 2010;171:106–110.
  297. Clayton HM, Duncan JL. Natural infection with Dictyocaulus arnfieldi in pony and donkey foals.. Res Vet Sci 1981;31:278–280.
  298. Nicholls JM, Clayton HM, Pirie HM, Duncan JL. A pathological study of the lungs of foals infected experimentally with Parascaris equorum.. J Comp Pathol 1978;88:261–274.
  299. Schmidt GM, Krehbiel JD, Coley SC, Leid RW. Equine ocular onchocerciasis: histopathologic study.. Am J Vet Res 1982;43:1371–1375.
  300. Paraschou G, Adako GM, Priestnall SL, Burden FA. Suspensory ligament desmitis caused by Onchocerca sp. in three donkeys.. Vet Pathol 2021;58:401–404.
  301. Hestvik G, Ekman S, Lindberg R. Onchocercosis of an intervertebral joint capsule causing cervical vertebral stenotic myelopathy in a horse.. J Vet Diagn Invest 2006;18:307–310.
  302. Mellor PS. Studies on Onchocerca cervicalis Railliet and Henry 1910: II. Pathology in the horse.. J Helminthol 1973;47:111–118.
  303. Collobert C, Bernard N, Lamidey C. Prevalence of Onchocerca species and Thelazia lacrimalis in horses examined postmortem in Normandy.. Vet Rec 1995;136:463–465.
  304. Solismaa M, Laaksonen S, Nylund M, Pitkänen E, Airakorpi R, Oksanen A. Filarioid nematodes in cattle, sheep and horses in Finland.. Acta Vet Scand 2008;50:20.
  305. Lyons ET, Drudge JH, Tolliver SC. Verification of ineffectual activity of ivermectin against adult Onchocerca spp in the ligamentum nuchae of horses.. Am J Vet Res 1988;49:983–985.
  306. Mansell SE, Behnke MC. Onchocerca cervicalis: a survey into awareness and knowledge of the parasite amongst UK equine veterinarians.. J Equine Vet 2022;114:103942.
  307. Lyons ET, Tolliver SC, Drudge JH, Swerczek TW, Crowe MW. Prevalence of some internal parasites recovered at necropsy of thoroughbreds born in 1982 in Kentucky.. Am J Vet Res 1985;46:679–683.
  308. Arbuckle J, Khalil L. Thelazia lacrymalis in the eyelids of British horses.. Vet Rec 1978;103:158.
  309. Hillyer L, Coles G, Randle R. Setaria equina in the UK.. Vet Rec 2001;149:464.
  310. Regnier A, Martin C, Semin M, Lienard E, Geffre A, Douet J. Subconjunctival nodule due to Setaria equina erratic migration in a horse: first case report.. Vet Ophthalmol 2019;22:921–927.
  311. Hornok S, Genchi C, Bazzocchi C, Fok E, Farkas R. Prevalence of Setaria equina microfilaraemia in horses in Hungary.. Vet Rec 2007;161(814):816.
  312. Hwang H, Ro Y, Lee H, Kim J, Lee K, Choi E‐J. Epidemiological investigation of equine hindlimb ataxia with Setaria digitata in South Korea.. J Vet Sci 2021;23:e75.
  313. Shin J, Ahn K‐S, Suh G‐H, Kim H‐J, Jeong H‐S, Kim B‐S. First blindness cases of horses infected with Setaria digitata (Nematoda: Filarioidea) in the Republic of Korea.. Korean J Parasitol 2017;55:667–671.
  314. Lyons ET, Drudge JH, Tolliver SC. On the life cycle of Strongyloides westeri in the equine.. J Parasitol 1973;59:780–787.
  315. Brown CA, MacKay RJ, Chandra S, Davenport D, Lyons ET. Overwhelming strongyloidosis in a foal.. J Am Vet Med Assoc 1997;211:333–334.
  316. Netherwood T, Wood JLN, Townsend HGG, Mumford JA, Chanter N. Foal diarrhoea between 1991 and 1994 in the United Kingdom associated with Clostridium perfringens, rotavirus, Strongyloides westeri and cryptosporidium spp.. Epidemiol Infect 1996;117:375–383.
  317. Olivo G, Lucas TM, Borges AS, Silva ROS, Lobato FCF, Siqueira AK. Enteric pathogens and coinfections in foals with and without diarrhea.. Biomed Res Int 2016;2016:1512690.
  318. Lyons ET, Tolliver SC, Drudge JH, Granstrom DE, Collins SS. Natural infections of Strongyloides westeri: prevalence in horse foals on several farms in Central Kentucky in 1992.. Vet Parasitol 1993;50:101–107.
  319. Ludwig KG, Craig TM, Bowen JM, Ansari MM, Ley WB. Efficacy of ivermectin in controlling Strongyloides westeri infections in foals.. Am J Vet Res 1983;44:314–316.
  320. Kirtland A, McAloon C, Walshe N, Duggan V. Strongyloides westeri infection on a thoroughbred breeding farm in Ireland (2014–2019): prevalence, risk factors and peripartum ivermectin.. Equine Vet Educ 2023;35:e438–e450.
  321. Lapointe J‐M, Céleste C, Villeneuve A. Septic peritonitis due to colonic perforation associated with aberrant migration of a gasterophilus intestinalis larva in a horse.. Vet Pathol 2003;40:338–339.
  322. Tadmor A, Perl S, Weinberg H. Infestation of a mare's liver with Gasterophilus intestinalis.. Vet Med Small Anim Clin Vm Sac 1981;76:85–86.
  323. Vemming DC, Steenkamp G, Carstens A, Olorunju SAS, Stroehle RM, Page PC. Prevalence of dental disorders in an abattoir population of horses in South Africa by oral examination of intact and bisected heads.. Vet J 2015;205:110–112.
  324. Griss R, Simhofer H. First‐time endoscopic detection of larvae of Gasterophilus spp. in the oral cavity in 14 warmblood horses.. Berl Munch Tierarztl 2006;119:416–420.
  325. Smith MA, McGarry JW, Kelly DF, Proudman CJ. Gasterophilus pecorum in the soft palate of a British pony.. Vet Rec 2005;156:283.
  326. Cogley TP, Cogley MC. Field observations of the host–parasite relationship associated with the common horse bot fly, Gasterophilus intestinalis.. Vet Parasitol 2000;88:93–105.
  327. Cogley TP, Anderson JR, Cogley LJ. Migration of Gasterophilus intestinalis larvae (Diptera: Gasterophilidae) in the equine oral cavity.. Int J Parasitol 1982;12:473–480.
  328. Tolliver SC, Lyons ET, Drudge JH. Observations on the specific location of Gasterophilus spp. larvae in the mouth of the horse.. J Parasitol 1974;60:891–892.
  329. Cogley TP, Cogley MC. Inter‐relationship between Gasterophilus larvae and the horse's gastric and duodenal wall with special reference to penetration.. Vet Parasitol 1999;86:127–142.
  330. Dart AJ, Hutchins DR, Begg AP. Suppurative splenitis and peritonitis in a horse after gastric ulceration caused by larvae of Gasterophilus intestinalis.. Aust Vet J 1987;64:155–158.
  331. Sgorbini M, Bonelli F, Papini R, Busechian S, Briganti A, Laus F. Equine gastric ulcer syndrome in adult donkeys: investigation on prevalence, anatomical distribution, and severity.. Equine Vet Educ 2017;47:684–685.
  332. Junco M, Iglesias LE, Sagués MF, Guerrero I, Zegbi S, Saumell CA. Effect of macrocyclic lactones on nontarget coprophilic organisms: a review.. Parasitol Res 2021;120:773–783.
  333. Sands B, Noll M. Toxicity of ivermectin residues in aged farmyard manure to terrestrial and freshwater invertebrates.. Insect Conserv Divers 2022;15:9–18.
  334. Lumaret J‐P, Errouissi F. Use of anthelmintics in herbivores and evaluation of risks for the non target fauna of pastures.. Vet Res 2002;33:547–562.
  335. Floate KD, Wardhaugh KG, Boxall A, Sherratt TN. Faecal residues of veterinary parasiticides: nontarget effects in the pasture environment.. Annu Rev Entomol 2005;50:153–179.
  336. Herd RP, Stinner BR, Purrington FF. Dung dispersal and grazing area following treatment of horses with a single dose of ivermectin.. Vet Parasitol 1993;48:229–240.
  337. Perez R, Cabezas I, Godoy C, Rubilar L, Diaz L, Munoz L. Disposición plasmática y fecal de moxidectina administrada por vía oral en caballos.. Arch Med Vet 2001;33:33.
  338. Afzal J, Burke AB, Batten PL, DeLay RL, Miller P. Moxidectin: metabolic fate and blood pharmacokinetics of 14C‐labeled moxidectin in horses.. J Agr Food Chem 1997;45:3627–3633.
  339. Perez R, Cabezas I, Sutra JF, Galtier P, Alvinerie M. Faecal excretion profile of moxidectin and ivermectin after oral administration in horses.. Vet J 2001;161:85–92.
  340. Gokbulut C, Nolan AM, McKellar QA. Plasma pharmacokinetics and faecal excretion of ivermectin, doramectin and moxidectin following oral administration in horses.. Equine Vet J 2001;33:494–498.
  341. Strong L. Overview: the impact of avermectins on pastureland ecology.. Vet Parasitol 1993;48:3–17.
  342. Suárez VH, Lifschitz AL, Sallovitz JM, Lanusse CE. Effects of faecal residues of moxidectin and doramectin on the activity of arthropods in cattle dung.. Ecotox Environ Safe 2009;72:1551–1558.
  343. Mooney D, Richards KG, Danaher M, Grant J, Gill L, Mellander P‐E. An analysis of the spatio‐temporal occurrence of anthelmintic veterinary drug residues in groundwater.. Sci Total Environ 2021;769:144804.
  344. Sanderson H, Laird B, Pope L, Brain R, Wilson C, Johnson D. Assessment of the environmental fate and effects of ivermectin in aquatic mesocosms.. Aquat Toxicol 2007;85:229–240.
  345. Vokřál I, Michaela Š, Radka P, Jiří L, Lukáš P, Dominika S. Ivermectin environmental impact: excretion profile in sheep and phytotoxic effect in Sinapis alba.. Ecotox Environ Safe 2019;169:944–949.
  346. Eichberg C, Wohde M, Müller K, Rausch A, Scherrmann C, Scheuren T. The anthelmintic ingredient moxidectin negatively affects seed germination of three temperate grassland species.. PloS One 2016;11:e0166366.
  347. Stratford CH, Lester HE, Morgan ER, Pickles KJ, Relf V, Mcgorum BC. A questionnaire study of equine gastrointestinal parasite control in Scotland.. Equine Vet J 2014;46:25–31.
  348. Vineer HR, Velde FV, Bull K, Claerebout E, Morgan ER. Attitudes towards worm egg counts and targeted selective treatment against equine cyathostomins.. Prev Vet Med 2017;144:66–74.
  349. Ireland JL, Wylie CE, Collins SN, Verheyen KLP, Newton JR. Preventive health care and owner‐reported disease prevalence of horses and ponies in Great Britain.. Res Vet Sci 2013;95:418–424.
  350. Allison K, Taylor NM, Wilsmore AJ, Garforth C. Equine anthelmintics: survey of the patterns of use, beliefs and attitudes among horse owners in the UK.. Vet Rec 2011;168:483.
  351. Tzelos T, Morgan ER, Easton S, Hodgkinson JE, Matthews JB. A survey of the level of horse owner uptake of evidence‐based anthelmintic treatment protocols for equine helminth control in the UK.. Vet Parasitol 2019;274:108926.
  352. Comer KC, Hillyer MH, Coles GC. Anthelmintic use and resistance on thoroughbred training yards in the UK.. Vet Rec 2006;158:596.
  353. Lloyd S, Smith J, Connan RM, Hatcher MA, Hedges TR, Humphrey DJ. Parasite control methods used by horse owners: factors predisposing to the development of anthelmintic resistance in nematodes.. Vet Rec 2000;146:487.
  354. Mellor DJ, Reid SWJ, Love S, Walker R, Gettinby G. Sentinel practice‐based survey of the management and health of horses in northern Britain.. Vet Rec 2001;149:417.
  355. Pascoe RJ, Wilson TJ, Coles GC. Nematode control in eventer horses.. Vet Rec 1999;145:200.
  356. Earle CG, Kington HA, Coles GC. Helminth control used by trainers of thoroughbreds in England.. Vet Rec 2002;150:405–408.
  357. Easton S, Pinchbeck GL, Tzelos T, Bartley DJ, Hotchkiss E, Hodgkinson JE. Investigating interactions between UK horse owners and prescribers of anthelmintics.. Prev Vet Med 2016;135:17–27.
  358. Easton S, Bartley DJ, Hotchkiss E, Hodgkinson JE, Pinchbeck GL, Matthews JB. Use of a multiple choice questionnaire to assess UK prescribing channels' knowledge of helminthology and best practice surrounding anthelmintic use in livestock and horses.. Prev Vet Med 2016;128:70–77.
  359. Golding E, Neita AN, Walshe N, Hanlon A, Mulcahy G, Duggan V. Survey of the knowledge and perceptions of horse owners in Ireland of common clinical conditions and their impact.. Equine Vet J 2022;55(2):270–281.
  360. Easton S, Pinchbeck GL, Bartley DJ, Hotchkiss E, Hodgkinson JE, Matthews JB. A survey of UK prescribers' experience of, and opinions on, anthelmintic prescribing practices for livestock and equines.. Prev Vet Med 2016;134:69–81.
  361. McTigue FE, Mansbridge SC, Pyatt AZ. Equine anthelmintic resistance: horse owner and yard manager perception of the barriers affecting strategic control measures in England.. Vet Sci 2022;9:560.
Subscribe to our newsletter
Join 99,344 horse owners like you who receive our email updates on horse health and nutrition.